Chicken anaemia viruses of low pathogenicity
AssigneeAkzo Nobel N.V.
InventorsCarla Christina Schrier, Henricus Johannes Maria Jagt
Life of this patent
Estimating the term…
Abstract
The present invention provides a new antigenic type of chicken anaemia viruses (CAV). The CAV according to this invention is isolatable from turkeys in the field and its virulence for chickens is significantly reduced. This property makes these viruses particularly suited for preparing a live vaccine for protecting poultry against disease conditions resulting from CAV infection.
Claims7
A vaccine for protecting poultry against disease conditions resulting from a chicken anaemia virus (CAV) infection, comprising an effective dosage of a CAV having the identifying characteristics of the CAV strain 319, which is deposited at the ECACC under accession no. V00012608, and a pharmaceutically acceptable carrier or diluent.
Dependencies are inferred from the claim text.